Skip to main content
. 2024 Sep 16;20(13):5043–5055. doi: 10.7150/ijbs.97166

Figure 7.

Figure 7

Schematic mechanism underlying how Pad2 deficiency or inhibition mitigates Pseudomonas aeruginosa-induced lung injury. Our findings indicate that Pad2 deficiency or inhibition, particularly with the novel inhibitor AMF41a, not only enhances survival rates and diminishes bacterial proliferation but also enhances macrophage functionality through the augmentation of autophagy in mice.